News & Events
September 17, 2018
Why bluebird and Celgene Should Worry About Amgen’s Latest Clinical Victory
At a recent scientific conference, Amgen shared preliminary data from five patients with multiple myeloma so aggressive that their disease didn’t back down after four to six previous lines of treatment
September 16, 2018
This is the first FDA clearance for Apple and pushes the Watch further into healthcare than ever before.
This is the first FDA clearance for Apple and pushes the Watch further into healthcare than ever before.
September 12, 2018
Novartis announces Alcon move to Switzerland ahead of spin-out
Novartis announced that Alcon, the eye care division of Novartis, will spin off to become a standalone company in an aim for the former to focus on growth.
September 5, 2018
BioInnovation Day, Nov 15th 2018, Campus Biotech
BioInnovation Day 2018 will take place at Campus Biotech, Geneva’s life sciences hub
August 29, 2018
Gilead and Novartis’s CAR T-Cell Therapies Approved in Europe
European Commission announced it has given marketing approval for both Gilead’s Yescarta and Novartis’s Kymriah
August 27, 2018
Eye exam could spot your risk of Alzheimer’s disease long before symptoms arise
A routine eye exam may be able to screen people for early signs of Alzheimer’s disease, new research has found.
August 21, 2018
4 Future Scenarios For Cell And Gene Therapy Adoption
Four very different scenarios are explored that could unfold over the next decade. Based on extremes, these scenarios will expand traditional thinking and help life science companies determine the appropriate position and strategy
August 21, 2018
FDA’s New Guidance On Replication Competent Retrovirus Testing During Gene Therapy Manufacture
The draft guidance document provides recommendations regarding the testing for RCR during the manufacture of retroviral vector-based gene therapy products, and for follow-up monitoring of patients who have received retroviral vector-based gene therapy products.


The Eclosion Foundation is a non-for-profit organisation supported by the State of Geneva.
Fondation Eclosion
Admin/Laboratories
CTN 14 – 14, Chemin des Aulx
1228 Plan-les-Ouates – Genève
Switzerland
Tel: +41 (022) 880 10 10
Fax: +41 (022) 880 10 13
Fondation Eclosion
Espace Geneus
Campus Biotech Innovation Park
Bâtiment F2F3
Avenue Sécheron 15
1202 Genève
Switzerland